D.E. Shaw & Co’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
MF
WAM
AA
LP
TCM
KIM
PAMP
AIMCA
LA
D.E. Shaw & Co's TDAC Position: Q1 2026 in Review
D.E. Shaw & Co held its Translational Development Acquisition Corp (TDAC) position steady in Q1 2026 at 346,900 shares worth $3.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2413.
D.E. Shaw & Co first reported a position in TDAC in Q2 2025 and has held it in 4 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.
- D.E. Shaw & Co held 346,900 shares of Translational Development Acquisition Corp worth $3.66M as of Q1 2026.
- D.E. Shaw & Co left its Translational Development Acquisition Corp share count unchanged in Q1 2026.
- Translational Development Acquisition Corp made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2413 holding.
- D.E. Shaw & Co first reported a position in Translational Development Acquisition Corp in Q2 2025 and has held it in 4 quarters since.
- 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.